These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6255477)

  • 1. Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma.
    Cheng YC; Chen JY; Glaser R; Henle W
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6162-5. PubMed ID: 6255477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.
    Henle G; Henle W
    Int J Cancer; 1976 Jan; 17(1):1-7. PubMed ID: 175020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
    Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of nasopharyngeal carcinoma by means of recombinant Epstein-Barr virus proteins.
    Littler E; Baylis SA; Zeng Y; Conway MJ; Mackett M; Arrand JR
    Lancet; 1991 Mar; 337(8743):685-9. PubMed ID: 1672175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody to Epstein-Barr virus-specific DNase in patients with nasopharyngeal carcinoma.
    Chen JY; Liu MY; Lynn TC; Yang CS
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 Nov; 15(4):255-61. PubMed ID: 6305599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of Epstein-Barr virus deoxyribonuclease enzyme activity-neutralizing antibodies. An index of Epstein-Barr virus disease.
    Bardy B; Morinet F; Pérol Y
    Intervirology; 1989; 30(1):36-43. PubMed ID: 2542178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses to Epstein-Barr virus-specific DNase in relation to the prognosis of juvenile patients with nasopharyngeal carcinoma.
    Tan RS; Cheng YC; Naegele RF; Henle W; Glaser R; Champion J
    Int J Cancer; 1982 Nov; 30(5):561-5. PubMed ID: 6295964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response to Epstein-Barr-virus-specific DNase in 13 patients with nasopharyngeal carcinoma in Taiwan: a retrospective study.
    Chen JY; Hwang LY; Beasley RP; Chien CS; Yang CS
    J Med Virol; 1985 Jun; 16(2):99-105. PubMed ID: 2989423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of IgG and IgA antibodies to Epstein-Barr virus membrane antigen in sera from patients with nasopharyngeal carcinoma and from normal individuals.
    Zhu XX; Zeng Y; Wolf H
    Int J Cancer; 1986 May; 37(5):689-91. PubMed ID: 3009331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody to Epstein-Barr virus-specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan.
    Chen JY; Chen CJ; Liu MY; Cho SM; Hsu MM; Lynn TC; Shieh T; Tu SM; Beasley RP; Hwang LY
    J Med Virol; 1989 Apr; 27(4):269-73. PubMed ID: 2542436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [IgG- and IgA-antibodies to the Epstein-Barr virus in the sera of patients with nasopharyngeal carcinoma in Cuba].
    Gurtsevich VE; Ruíz García R; Cuevas J; Le Riverand Morales E; Ascue M
    Vopr Virusol; 1979; (4):392-9. PubMed ID: 225887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of antibodies to Epstein-Barr virus DNase and viral capsid antigen for prognostication of patients with nasopharyngeal carcinoma.
    Hsu MM; Chen JY; Chen CJ
    Taiwan Yi Xue Hui Za Zhi; 1988 Oct; 87(10):984-8. PubMed ID: 2853721
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody to Epstein-Barr virus-specific DNase as a marker for the early detection of nasopharyngeal carcinoma.
    Chen JY; Liu MY; Chen CJ; Hsu MM; Tu SM; Lee HH; Kuo SL; Yang CS
    J Med Virol; 1985 Sep; 17(1):47-9. PubMed ID: 2995572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of virus-specific antibodies to EBV-antigens in patients with nasopharyngeal carcinoma (author's transl)].
    Wilmes E; Wolf H; Deinhardt F; Naumann HH
    Laryngol Rhinol Otol (Stuttg); 1979 Dec; 58(12):911-5. PubMed ID: 231716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of Epstein-Barr virus-specific DNA polymerase in chemically induced Raji cells and its antibody in serum from patients with nasopharyngeal carcinoma.
    Tan RS; Li JS; Grill SP; Nutter LM; Cheng YC
    Cancer Res; 1986 Oct; 46(10):5024-8. PubMed ID: 3019519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to Epstein-Barr virus-specific DNase in patients with nasopharyngeal carcinoma and control groups.
    Chen JY; Chen CJ; Liu MY; Cho SM; Hsu MM; Lynn TC; Shieh T; Tu SM; Lee HH; Kuo SL
    J Med Virol; 1987 Sep; 23(1):11-21. PubMed ID: 2824675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antibodies to Epstein-Barr virus in Italian patients with nasopharyngeal carcinoma.
    Cevenini R; Donati M; Caliceti U; Moroni A; Tamba I; Rumpianesi F
    J Infect; 1986 Mar; 12(2):127-31. PubMed ID: 3009628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome.
    Jones JF; Williams M; Schooley RT; Robinson C; Glaser R
    Arch Intern Med; 1988 Sep; 148(9):1957-60. PubMed ID: 2843138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.
    Ho HC; Ng MH; Kwan HC; Chau JC
    Br J Cancer; 1976 Dec; 34(6):655-60. PubMed ID: 188437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.